NHS HEYWOOD, MIDDLETON AND ROCHDALE CCG
3RD FLOOR, NUMBER ONE RIVERSIDE, SMITH STREET, ROCHDALE See member list for this organisation
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 461 | 564 | 81.7% | |
| HF 4 | 2012 | 512 | 613 | 83.5% | |
| HF 4 | 2013 | 572 | 668 | 85.6% | |
| HF004 | 2014 | 383 | 431 | 88.9% | |
| HF004 | 2015 | 434 | 482 | 90.0% | |
| HF004 | 2016 | 449 | 499 | 90.0% | |
| HF004 | 2017 | 458 | 511 | 89.6% | |
| HF004 | 2018 | 539 | 590 | 91.4% | |
| HF004 | 2019 | 569 | 623 | 91.3% | |
| HF004 | 2020 | 618 | 692 | 89.3% | |
| HF006 | 2021 | 789 | 868 | 90.9% | |
| HF006 | 2022 | 819 | 1108 | 73.9% | |
| HF006 | 2023 | 1035 | 1076 | 96.2% |
